Description
4-Tert-butyl-5-methoxy-1,2-quinone exhibits anticancer activity, inhibiting proliferation of leukemia cells.
| Product Unit Size | Cost | Quantity | Stock |
|---|
4-Tert-butyl-5-methoxy-1,2-quinone exhibits anticancer activity, inhibiting proliferation of leukemia cells.
| Cas No. | 36122-03-9 |
|---|---|
| Purity | ≥95% |
| Formula | C11H14O3 |
| Formula Wt. | 194.25 |
| IUPAC Name | 4-tert-butyl-5-methoxycyclohexa-3,5-diene-1,2-dione |
| Melting Point | 92-95°C |
| Appearance | Red powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Lam LK, Garg PK, Swanson SM, et al. Evaluation of the cytotoxic potential of catechols and quinones structurally related to butylated hydroxyanisole. J Pharm Sci. 1988 May;77(5):393-5. PMID: 3411459.
c-MET inhibitor.
Polypeptide; peptidoglycan inhibitor.
Dual inhibitor of p70S6K and Akt.
Induces cardiomyogenic effects in pluripotent c...
ALK5 (activin-like) inhibitor.
Mycotoxin contaminant found in cereal grains.
Kynurenine 3-hydroxylase inhibitor.
Organoselenium compound found in selenium-enric...
β-adrenergic antagonist.
Thienylbutyl ITC analog.
α1-adrenergic antagonist.
Steroidogenesis inhibitor
Endogenous tachykinin peptide, involved in infl...
Fluoroquinolone; topoisomerase IV, topoisomeras...
Synthetic progestogen; contraceptive.
Thiazole; proteasome inhibitor, protein translo...
TNKS1/2 inhibitor.
Endogenous opioid peptide; δOR and μOR agonis...
TTK/CLK2 inhibitor.
NDRI inhibitor